Pharming Group (NASDAQ:PHAR) Earns Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Pharming Group (NASDAQ:PHAR – Free Report) in a research note released on Thursday morning,Benzinga reports. They currently have a $37.00 target price on the stock. A number of other research analysts have also recently commented on PHAR. Jefferies Financial Group began coverage on shares of Pharming […]
HC Wainwright reissued their buy rating on shares of Pharming Group (NASDAQ:PHAR – Free Report) in a research note released on Thursday morning,Benzinga reports. They currently have a $37.00 target price on the stock. A number of other research analysts have also recently commented on PHAR. Jefferies Financial Group began coverage on shares of Pharming […]
